ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 627168 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 627168; 2) Community: the network communities that were significantly associated with the response to NSC 627168; 3) Molecule: the relationships between components within communities and NSC 627168; 4) MDR: the compounds that were significantly associated with the NSC 627168.

NSC Compound Enrichment Correlation
NSC 303861 L-Cysteine analog 0.0209467683758286 0.44264307
NSC 3077 s-Triazine, 4,6-diamino-1-(3,4-dichlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) 0.0209467683758286 0.43097649
NSC 328410 Camptothecin Derivative 0.0209467683758286 0.25879873
NSC 5332 2-Hydroxy-1-(2-pyridylazo)naphthalene 0.0209467683758286 0.38429916
NSC 603578 Platinum, tetrachloro[dimethylsilylenebis(methanamine)]-, (OC-6-22) 0.0209467683758286 0.2404807
NSC 606497 Camptothecin Derivative 0.0209467683758286 0.27084705
NSC 638409 (E)N-Ethyl-[3-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl) prop-2-enoamide 0.0209467683758286 0.12021666
NSC 63878 Cytarabine Hydrochloride AZ 0.0209467683758286 0.30694225
NSC 642324 Null 0.0209467683758286 0.21585611
NSC 649904 Cyclopentanone, 5-[(4-morpholinyl)methyl]-2-pentylidene-, hydrochloride 0.0209467683758286 0.25596446
Total:81  Current:37    [First] [Prev] [Next] [Last]